1. Home
  2. AUPH vs MEG Comparison

AUPH vs MEG Comparison

Compare AUPH & MEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • MEG
  • Stock Information
  • Founded
  • AUPH 1993
  • MEG 2012
  • Country
  • AUPH Canada
  • MEG United States
  • Employees
  • AUPH N/A
  • MEG N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • MEG Professional Services
  • Sector
  • AUPH Health Care
  • MEG Consumer Discretionary
  • Exchange
  • AUPH Nasdaq
  • MEG Nasdaq
  • Market Cap
  • AUPH 1.3B
  • MEG 591.7M
  • IPO Year
  • AUPH 1999
  • MEG 2020
  • Fundamental
  • Price
  • AUPH $8.77
  • MEG $18.75
  • Analyst Decision
  • AUPH Strong Buy
  • MEG Buy
  • Analyst Count
  • AUPH 3
  • MEG 6
  • Target Price
  • AUPH $10.33
  • MEG $35.67
  • AVG Volume (30 Days)
  • AUPH 1.3M
  • MEG 678.6K
  • Earning Date
  • AUPH 02-13-2025
  • MEG 11-06-2024
  • Dividend Yield
  • AUPH N/A
  • MEG N/A
  • EPS Growth
  • AUPH N/A
  • MEG N/A
  • EPS
  • AUPH N/A
  • MEG N/A
  • Revenue
  • AUPH $220,361,000.00
  • MEG $673,079,000.00
  • Revenue This Year
  • AUPH $36.97
  • MEG $13.57
  • Revenue Next Year
  • AUPH $16.43
  • MEG $9.96
  • P/E Ratio
  • AUPH N/A
  • MEG N/A
  • Revenue Growth
  • AUPH 38.72
  • MEG 12.56
  • 52 Week Low
  • AUPH $4.71
  • MEG $15.21
  • 52 Week High
  • AUPH $10.67
  • MEG $49.97
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 45.91
  • MEG 52.81
  • Support Level
  • AUPH $8.89
  • MEG $16.79
  • Resistance Level
  • AUPH $9.31
  • MEG $18.52
  • Average True Range (ATR)
  • AUPH 0.34
  • MEG 1.37
  • MACD
  • AUPH -0.11
  • MEG 0.46
  • Stochastic Oscillator
  • AUPH 1.43
  • MEG 71.83

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.

Share on Social Networks: